Skip to content

Urban Health Study II

Finding, Testing and Treating High-Risk Probationers and Parolees With HIV

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01402466
Enrollment
49
Registered
2011-07-26
Start date
2011-08-31
Completion date
2014-12-31
Last updated
2016-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV

Keywords

Drug users, criminal justice, HIV care, HAART, incarceration

Brief summary

The study will test an intervention to help HIV-positive people achieve consistency of HIV care while transitioning in and out of jail.

Detailed description

The study has two research objectives: (1) to expand access and options for HIV testing with individuals in the criminal justice system, by focusing on high-risk intravenous drug users (IDUs) and crack cocaine smokers in community settings; and (2) to improve access and maintenance of highly active antiretroviral treatment (HAART) among HIV-positive persons in this population, by implementing a promising intervention focused on continuity of HIV care, and evaluating it using a rigorous experimental design. HIV-positive persons will be identified through the testing activities described in Objective 1. They will then be offered enrollment in a randomized controlled trial (RCT) of an intervention designed to engage and maintain HIV-positive people with criminal justice involvement in medical care. The intervention, Project Bridge, has shown great promise but has not yet been rigorously evaluated. The RCT will assess the efficacy of Project Bridge compared with a Usual Care arm. Our hypotheses are that, at quarterly data collection visits: (1) Intervention participants will have lower HIV viral load than usual care participants 2b: (2) Intervention participants will be more likely to be in HIV care than usual care participants (3) Intervention participants will be more likely to be on HAART than usual care participants. The study design was changed from a randomized controlled trial to a quasi-experimental comparison group design. This change was approved by the NIMH Program Officer and the RTI IRB in June, 2012.

Interventions

Participants randomized to this arm will be referred to local HIV care resources

BEHAVIORALProject Bridge

Arm 2

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
RTI International
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Age 18 or older * HIV antibody positive * not currently receiving HIV care

Exclusion criteria

* already in care * unable to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Log10 viral loadEvery 3 months for 2 yearsChanges in viral load over time will be compared between the standard referral and Project Bridge Groups

Secondary

MeasureTime frameDescription
Engagement in HIV CareEvery 3 months for 2 yearsThe proportion of participants entering HIV care will be compared between the standard referral and Project Bridge groups
Initiation of Highly Active Antiretroviral Therapy (HAART)Every 3 months for 2 yearsThe proportion of participants initiating HAART will be compared between the standard referral and Project Bridge groups

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026